Kbc Group Nv Medpace Holdings, Inc. Transaction History

Kbc Group Nv

$36.3 Billion
Q4 2024

A detailed history of Kbc Group Nv transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 1,153 shares of MEDP stock, worth $408,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,153

Previous 1,213 4.95%

Holding current value

$408,750

Previous $405,000 5.43%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$308.93 - $363.58 $18,535 - $21,814	-60 Reduced 4.95%	1,153 $383,000
Q3 2024 Nov 06, 2024	BUY	$320.58 - $457.29 $20,196 - $28,809	63 Added 5.48%	1,213 $405,000
Q2 2024 Jul 17, 2024	BUY	$372.0 - $424.34 $218,364 - $249,087	587 Added 104.26%	1,150 $474,000
Q1 2024 May 08, 2024	BUY	$284.87 - $413.31 $16,237 - $23,558	57 Added 11.26%	563 $228,000
Q4 2023 Feb 13, 2024	BUY	$227.52 - $312.68 $115,125 - $158,216	506 New	506 $155,000
Q2 2022 Jul 26, 2022	SELL	$130.2 - $168.03 $372,632 - $480,901	-2,862 Closed	0 $0
Q4 2021 Feb 14, 2024	BUY	$182.74 - $227.9 $430,535 - $536,932	2,356 Added 465.61%	2,862 $623,000
Q3 2020 Oct 28, 2020	SELL	$92.95 - $130.61 $51,122 - $71,835	-550 Reduced 16.12%	2,862 $320,000
Q1 2020 May 04, 2020	SELL	$61.71 - $101.95 $896,708 - $1.48 Million	-14,531 Reduced 80.98%	3,412 $250,000
Q2 2019 Jul 30, 2019	SELL	$53.64 - $65.42 $615,787 - $751,021	-11,480 Reduced 39.02%	17,943 $0
Q1 2019 May 10, 2019	BUY	$49.38 - $70.58 $1.45 Million - $2.08 Million	29,423 New	29,423 $0

Others Institutions Holding MEDP

# of Institutions

620

Shares Held

25.3M

Call Options Held

81.2K

Put Options Held

146K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $11B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account